Cargando…
Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt
BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Ou...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106521/ https://www.ncbi.nlm.nih.gov/pubmed/35573077 http://dx.doi.org/10.1155/2022/7833623 |
_version_ | 1784708305106501632 |
---|---|
author | Ezz Eldin, Azza M. Kamal, Dalia Tarik Salah Eldin, Samar Elkhayat, Mariam R. Attia, Alaa M. Abd Elhameed, Zeinab Ahmed |
author_facet | Ezz Eldin, Azza M. Kamal, Dalia Tarik Salah Eldin, Samar Elkhayat, Mariam R. Attia, Alaa M. Abd Elhameed, Zeinab Ahmed |
author_sort | Ezz Eldin, Azza M. |
collection | PubMed |
description | BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Our primary objective in this study was to evaluate SARS-CoV-2 Ab testing as a screening tool for detecting COVID-19 infection among asymptomatic LHCWs. Our secondary aims were to establish the relationship between exposure to COVID-19 infection and subsequent asymptomatic disease and working in different areas of the laboratory. METHOD: The detection of SARS-CoV-2 antibodies was done by different methods (rapid testing, electrochemiluminescence, and chemiluminescent microparticle immunoassay). The study included 199 asymptomatic LHCWs at Assiut University Hospital, Egypt, from different laboratory areas including molecular biology, microbiology, parasitology, and outpatient clinic laboratories in addition to LHCWs involved in automation, phlebotomy, rotating physicians, and those working in the sample receiving area. RESULTS: The incidence of SARS-CoV-2 antibodies by rapid testing and immunoassay among asymptomatic LHCWs was 29.6% and 24.4%. Laboratory phlebotomists (55.6%) were most likely to be exposed to positive patients and samples, followed by those working in the sample receiving area (32%), LHCWs in the automation area (29.6%), rotating doctors (28.6%), and LHCWs in the diagnostic molecular biology laboratory (15.4%). The sensitivities of the rapid test and SARS-CoV-2 total antibody were 94.1% and 92%, whereas the specificities were 92.6% and 91%. CONCLUSION: Rapid serological testing is an effective screening method for the detection of SARS-CoV-2 infection among asymptomatic LHCWs and the identification of the groups of workers who have a significantly higher seroprevalence than the rest of the laboratory population. |
format | Online Article Text |
id | pubmed-9106521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91065212022-05-14 Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt Ezz Eldin, Azza M. Kamal, Dalia Tarik Salah Eldin, Samar Elkhayat, Mariam R. Attia, Alaa M. Abd Elhameed, Zeinab Ahmed J Environ Public Health Research Article BACKGROUND: COVID-19 is an illness caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory healthcare workers (LHCWs) are at highest risk for COVID-19 infection due to direct exposure to COVID-19 patients and/or infected samples. OBJECTIVES: Our primary objective in this study was to evaluate SARS-CoV-2 Ab testing as a screening tool for detecting COVID-19 infection among asymptomatic LHCWs. Our secondary aims were to establish the relationship between exposure to COVID-19 infection and subsequent asymptomatic disease and working in different areas of the laboratory. METHOD: The detection of SARS-CoV-2 antibodies was done by different methods (rapid testing, electrochemiluminescence, and chemiluminescent microparticle immunoassay). The study included 199 asymptomatic LHCWs at Assiut University Hospital, Egypt, from different laboratory areas including molecular biology, microbiology, parasitology, and outpatient clinic laboratories in addition to LHCWs involved in automation, phlebotomy, rotating physicians, and those working in the sample receiving area. RESULTS: The incidence of SARS-CoV-2 antibodies by rapid testing and immunoassay among asymptomatic LHCWs was 29.6% and 24.4%. Laboratory phlebotomists (55.6%) were most likely to be exposed to positive patients and samples, followed by those working in the sample receiving area (32%), LHCWs in the automation area (29.6%), rotating doctors (28.6%), and LHCWs in the diagnostic molecular biology laboratory (15.4%). The sensitivities of the rapid test and SARS-CoV-2 total antibody were 94.1% and 92%, whereas the specificities were 92.6% and 91%. CONCLUSION: Rapid serological testing is an effective screening method for the detection of SARS-CoV-2 infection among asymptomatic LHCWs and the identification of the groups of workers who have a significantly higher seroprevalence than the rest of the laboratory population. Hindawi 2022-05-06 /pmc/articles/PMC9106521/ /pubmed/35573077 http://dx.doi.org/10.1155/2022/7833623 Text en Copyright © 2022 Azza M. Ezz Eldin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ezz Eldin, Azza M. Kamal, Dalia Tarik Salah Eldin, Samar Elkhayat, Mariam R. Attia, Alaa M. Abd Elhameed, Zeinab Ahmed Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title | Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title_full | Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title_fullStr | Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title_full_unstemmed | Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title_short | Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt |
title_sort | prevalence of sars-cov-2 antibodies in laboratory healthcare workers at assiut university hospital, egypt |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106521/ https://www.ncbi.nlm.nih.gov/pubmed/35573077 http://dx.doi.org/10.1155/2022/7833623 |
work_keys_str_mv | AT ezzeldinazzam prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt AT kamaldaliatarik prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt AT salaheldinsamar prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt AT elkhayatmariamr prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt AT attiaalaam prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt AT abdelhameedzeinabahmed prevalenceofsarscov2antibodiesinlaboratoryhealthcareworkersatassiutuniversityhospitalegypt |